Targeting “monster cancer cells” could reduce recurrence rates after cancer therapy
MUSC Hollings Cancer Center researchers have unlocked a discovery that could help to explain why cancer can recur in patients who have undergone chemotherapy or radiotherapy. Credit: Medical University of South Carolina. Photograph by Sarah Pack. MUSC Hollings Cancer Center researchers have unlocked a discovery